What is Stem Cell International?
Stem Cell International specializes in adult stem cell regenerative medicine, with a strategic focus on making these advanced therapies more affordable, accessible, and of high quality. Since its inception in 2015, the company has been dedicated to providing innovative treatments, including stem cell therapy and Platelet-Rich Plasma (PRP), to individuals suffering from a range of inflammatory and degenerative conditions. Their services cater to those with knee, hip, and shoulder injuries, as well as back pain and other related ailments, offering free consultations to assess patient candidacy.
How much funding has Stem Cell International raised?
Stem Cell International has raised a total of $42K across 1 funding round:
Debt
$42K
Debt (2021): $42K with participation from PPP
What's next for Stem Cell International?
The recent influx of capital, described as substantial expansion capital, positions Stem Cell International for significant growth and operational scaling. Operating at a significant Series B/C stage, this investment is likely to fuel further research and development, enhance treatment delivery capabilities, and potentially expand the company's market reach. The company's commitment to affordability and access suggests a strategy aimed at capturing a broader patient demographic within the burgeoning regenerative medicine market.
See full Stem Cell International company page
